Deals & Cases
- Deal Ticker: Kellerhals Carrard supports Galenica to enter the diagnostics business by acquiring Labor Team
- Deal Ticker: Kellerhals Carrard advises TecMed on the Acquisition of Ypsomed Diabetes Care to Build Global Insulin Powerhouse
- Deal-Ticker: Kellerhals Carrard berät bei CHF 122.5 Mio. Kapitalerhöhung und Kotierung von 1'000'000 neuen Aktien der Ypsomed Holding an der SIX Swiss Exchange
